fda approval of brigatinib for alk nsclc
Published 7 years ago • 202 plays • Length 4:37Download video MP4
Download video MP3
Similar videos
-
2:35
dr. west on fda approval of brigatinib in alk nsclc
-
9:00
fda d.i.s.c.o.: two approvals for alk-positive non-small cell lung cancer
-
1:21
nice approval of brigatinib in alk-positive nsclc
-
9:33
second-line brigatinib for alk/ros1-rearranged nsclc
-
1:34
dr. camidge on the alta study of brigatinib in nsclc
-
1:38
dr. drilon on the safety profile of brigatinib in alk nsclc
-
8:16
alta ii trial of brigatinib in alk-rearranged nsclc
-
1:52
dr. drilon on the utility of brigatinib in alk nsclc
-
0:55
dr. west on fda approval of frontline alectinib in alk nsclc
-
4:15
nice approval: brigatinib in alk nsclc
-
9:33
second-line brigatinib for alk/ros1-rearranged nsclc
-
3:44
approval of alunbrig offers another option for alk positive nsclc, but further research is needed
-
1:39
dr. leach on brigatinib in alk-positive nsclc
-
1:07
dr. subbiah on the fda approval of pralsetinib in ret nsclc
-
5:19
brigatinib at disease progression of alk-rearranged nsclc
-
1:36
fda approval of durvalumab for stage iii unresectable nsclc
-
1:34
dr. pennell on the use of brigatinib in alk nsclc
-
3:04
management of frontline alk nsclc: brigatinib vs. alectinib
-
2:13
alk nsclc: brigatinib indication and alta trial